A Research Study of How a New Medicine Called Amycretin, Given as Tablets, Works in Japanese Men With Obesity
Status:
Completed
Trial end date:
2023-12-15
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate if a new study drug, NNC0487-0111, is safe and how it
works in the participant's body, when given as an oral tablet to Japanese participants.